The Current Ratio as of September 2024 (TTM) for Senti Biosciences, Inc. (SNTI) is 4.89

According to Senti Biosciences, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.89. This represents a change of -18.89% compared to the average of 6.03 of the last 4 quarters.

Senti Biosciences, Inc. (SNTI) Historical Current Ratio (quarterly & annually)

How has SNTI Current Ratio performed in the past?

The mean historical Current Ratio of Senti Biosciences, Inc. over the last ten years is 5.26. The current 4.89 Current Ratio has changed 9.19% with respect to the historical average. Over the past ten years (40 quarters), SNTI's Current Ratio was at its highest in in the March 2021 quarter at 87.36. The Current Ratio was at its lowest in in the March 2022 quarter at 0.20.

Senti Biosciences, Inc. (SNTI) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Senti Biosciences, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Senti Biosciences, Inc. (SNTI) Average Current Ratio

How has SNTI Current Ratio performed in the past?

The current Current Ratio of Senti Biosciences, Inc. (SNTI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Senti Biosciences, Inc. (SNTI) Current Ratio vs. Peers

How is SNTI’s Current Ratio compared to its peers?

Senti Biosciences, Inc.’s Current Ratio is greater than ZIVO Bioscience, Inc. (0.17), greater than Cadrenal Therapeutics, Inc. Common Stock (3.60), less than Foghorn Therapeutics Inc. (5.69), greater than Quoin Pharmaceuticals, Ltd. (3.35), less than SAB Biotherapeutics, Inc. (5.24), greater than Cingulate Inc. (1.20), greater than Bellicum Pharmaceuticals, Inc. (3.04), greater than Hillstream BioPharma, Inc. (2.25), greater than Lipella Pharmaceuticals Inc. (4.33), less than Fennec Pharmaceuticals Inc. (8.02), less than Monopar Therapeutics Inc. (6.59), less than Applied Molecular Transport Inc. (4.99), less than Neoleukin Therapeutics, Inc. (15.33), less than SAB Biotherapeutics, Inc. (5.24), less than Connect Biopharma Holdings Limited (4.99), less than Tyra Biosciences, Inc. (36.46), less than RAPT Therapeutics, Inc. (8.14), greater than Xilio Therapeutics, Inc. (2.02), less than Mineralys Therapeutics, Inc. (11.20),

Build a custom stock screener for Senti Biosciences, Inc. (SNTI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Senti Biosciences, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Senti Biosciences, Inc. (SNTI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Senti Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.